Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss can occur after treating diabetic ketoacidosis, especially with rapid weight loss and high soft drink intake.

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

Pranlukast and mirabegron may work as new diabetes drugs.

Empagliflozin helps heal diabetic wounds in rats by reducing inflammation and oxidative stress.

GLP-1 agonists may increase the risk of hair loss.

Rabbit skin with active hair growth shows thicker, redder areas due to larger, more numerous hair follicles and increased blood vessels.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Taking alfuzosin and finasteride together caused temporary vision loss in a glaucoma patient, but switching to tamsulosin helped.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Linagliptin slows down premature aging in certain mice.

Metformin and liraglutide improved symptoms of HAIR-AN syndrome in a child.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

Linagliptin may cause hair loss and skin blisters.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

Newer GLP-1 drugs like semaglutide may cause hair loss.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.